【摘要】 目的观察新加升降散治疗心血管神经症的临床疗效。方法将100例患者,随机分为治疗组(60例)和对照组(40例),分别以新加升降散和弥可保治疗15d,并随访3个月,观察其临床疗效。结果治疗后治疗组症状积分为(4.12±3.24)分,总有效率为93.3%;对照组症状积分为(7.01±3.45)分,总有效率为70.0%,均有显著性差异(P<0.05)。结论新加升降散对于治疗心血管神经症有良好疗效。更多还原

【Abstract】 Objective To observe the clinical efficacy of"Xinjia Shengjiang Powder"in treating cardiovascular neurosis. Method 100 subjects were randomized into treatment group and control group, and then respectively treated by this Powder and Mecobalamin,with a course of 15 days. Results The symptom score was 4.12±3.24 in treatment group and 7.01±3.45 in control group;the total effective rate was 93.3% in treatment group and 70.0% in control group,P < 0.01. Conclusion This Powder is rather effective for cardiovascular neurosis.更多还原